Mobix Labs, Inc. (NASDAQ:MOBX – Get Free Report) saw a significant decline in short interest during the month of November. As of November 15th, there was short interest totalling 266,900 shares, a decline of 35.8% from the October 31st total of 415,600 shares. Currently, 1.4% of the company’s stock are sold short. Based on an average daily trading volume, of 234,700 shares, the short-interest ratio is currently 1.1 days.
Hedge Funds Weigh In On Mobix Labs
A hedge fund recently bought a new stake in Mobix Labs stock. Wedbush Securities Inc. bought a new position in shares of Mobix Labs, Inc. (NASDAQ:MOBX – Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 38,070 shares of the company’s stock, valued at approximately $62,000. Wedbush Securities Inc. owned 0.14% of Mobix Labs as of its most recent SEC filing. 8.56% of the stock is currently owned by institutional investors.
Mobix Labs Stock Up 43.1 %
Mobix Labs stock traded up $0.37 during midday trading on Thursday, hitting $1.23. 3,507,573 shares of the stock were exchanged, compared to its average volume of 249,985. Mobix Labs has a 52-week low of $0.55 and a 52-week high of $12.50. The business’s 50-day moving average price is $0.82 and its 200-day moving average price is $1.29.
About Mobix Labs
Mobix Labs, Inc, a fabless semiconductor company, provides wireless and connectivity solutions for next generation communication systems, including C-Band and mmWave 5G and high bandwidth cable applications. Its products include True5G chipset solutions; true xero active optical cables and related products designed to deliver fiber optic connectivity for a range of applications, including 5G infrastructure, autonomous vehicles, Pro A/V, AR/VR, remote medical systems, and others; electromagnetic interference filters deployed in aerospace, military, defense, medical, and healthcare products.
Featured Stories
- Five stocks we like better than Mobix Labs
- What are earnings reports?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Canadian Penny Stocks: Can They Make You Rich?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- High Flyers: 3 Natural Gas Stocks for March 2022
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Mobix Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mobix Labs and related companies with MarketBeat.com's FREE daily email newsletter.